Method for purifying taxane compound

A technology of taxanes and purification methods, which is applied in the field of anhydrous crystalline taxane compounds, can solve the problems of large amount of resin, high cost, and long operation cycle, and achieve the effects of mild conditions, easy control, and simple operation

Active Publication Date: 2010-02-17
BIOCOMPOUNDS PHARMACEUTICAL INC
View PDF2 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Column chromatography is divided into two types: normal pressure and high pressure: normal pressure column chromatography has a slow separation speed and low efficiency, and cannot adapt to industrial continuous production; high pressure column chromatography is often used in the production of taxane products, but It is necessary to customize a special high-pressure chromatography column (or preparative chromatography column) system and silica gel filler, and the investment in equipment and consumables is large; at the same time, the batch size can only reach 200-300 grams, and the operation cycle is long
In addition, normal-pressure and high-pressure column chromatography can only be used for preliminary purification, and cannot be qualified once; in the process of column chromatography, due to the generation of exchange heat, the product will be degraded in a small amount; and column chromatography requires a large amount of solvent
[0009] Chinese patent CN101177421 discloses a method for preparing high-purity taxane compounds using macroporous adsorption resin, using an aqueous solution of an organic solvent as an eluent, and adopting a separation method of atmospheric pressure column chromatography; although this method reduces the amount of organic solvent However, the chromatographic separation speed is slow, the operation cycle is long, and the amount of resin is large, and the cost is high
However, due to the large number of alcoholic hydroxyl groups in taxane compounds, for anhydrous crystals, solvents such as ethanol and n-hexane can easily form hydrogen bonds with the compound molecules, resulting in solvation, and the solvent residue often stays at a relatively high level and is difficult to reduce.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for purifying taxane compound
  • Method for purifying taxane compound
  • Method for purifying taxane compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0130] Embodiment 1: the purification of paclitaxel

[0131] Impurities in crude paclitaxel:

[0132] For crude paclitaxel, its common impurities are: 10-deacetyl-Paclitaxel of paclitaxel (10-Deacetyl-Paclitaxel), epimer of paclitaxel (7-epi-paclitaxel, 7-Epi-Paclitaxel), the epimer The 10-position deacetylated (7-Epi-10-Deacetyl-Paclitaxel) and cephalomannine (Cephalomannine). The molecular structural formulas of these four impurities are as follows:

[0133]

[0134] Paclitaxel 10-position deacetylate

[0135]

[0136] 7-epitaxol

[0137]

[0138] 7-epitaxol 10 deacetylation

[0139]

[0140] cephalomannine

[0141] Paclitaxel purification process:

[0142] Primary recrystallization: Add 0.80KG of crude paclitaxel and 12L of chloroform / acetone (v / v=2 / 1) mixed solvent into a 30L reaction kettle at 10°C, and stir to dissolve. The organic phase was dried with 0.8 kg of anhydrous sodium sulfate for 4 hours. Remove sodium sulfate by filtration, control the tem...

Embodiment 2

[0150] Embodiment 2: Purification of Docetaxel

[0151] Docetaxel crude product contains impurities:

[0152] For the crude product of docetaxel, the common impurities are: 10-oxo-docetaxel (10-oxo-docetaxel) of docetaxel, epimers of docetaxel (7-epi-docetaxel, 7-Epi-docetaxel ) and the 10-oxyhydroxide of this epimer (7-Epi-10-oxo-docetaxel). The molecular structural formulas of these three impurities are as follows:

[0153]

[0154] Docetaxel 10-hydroxyl oxide

[0155]

[0156] 7-epidocetaxel

[0157]

[0158] 7-epidocetaxel 10-hydroxyl oxide

[0159] Purification process of docetaxel:

[0160] Primary recrystallization: Add 0.84KG of crude docetaxel and 6.5L of dichloromethane / acetone (v / v=2 / 1) mixed solvent into a 30L reaction kettle at 15°C, and stir to dissolve. The organic phase was dried with 0.7 kg of anhydrous magnesium sulfate for 3 hours. Remove magnesium sulfate by filtration, control the temperature at 5°C, slowly add 15L of n-hexane to crystalliz...

Embodiment 3

[0168] Example 3: Purification of 10-deacetylbaccatin III

[0169] Primary recrystallization: Add 0.2KG 10-deacetylbaccatin III crude product and 2L dichloromethane / acetone (v / v=2 / 1) mixed solvent into a 10L reaction flask at 25°C, stir to dissolve. The organic phase was dried with 0.1 kg of anhydrous magnesium sulfate for 3 hours. Remove magnesium sulfate by filtration, control the temperature at 25°C, slowly add 4L of n-hexane to crystallize under stirring, continue to heat and crystallize for 25 minutes, filter, and dry to obtain a recrystallized product;

[0170] Secondary recrystallization: Add the primary recrystallization product obtained in the previous step and 2L absolute ethanol into a 10L reaction flask at 25°C, and stir to dissolve. Control the temperature at 0°C, slowly add 4L of n-hexane to crystallize under stirring, continue to keep warm for crystallization for 25 minutes, filter, and dry to obtain the secondary recrystallization product;

[0171] Beating: a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
Login to view more

Abstract

The invention provides a method for purifying a taxane compound. The method comprises the processes of solvent drying, double recrystallization, once pulping and drying, can effectively remove impurities, water, ignition residues, mechanical and inorganic impurities and a residual solvent generated in the processes of preparing and storing the taxane compound; and the method has mild condition, simple and convenient operation and higher yield and is easy to control. The content of any single impurity of a refined product is lower than 0.1 percent by the detection of a high performance liquid chromatograph, and the total impurity content is lower than 0.5 percent; and the obtained refined product is the anhydrous crystallization taxane compound with high stability and content.

Description

technical field [0001] The present invention relates to a method for purifying taxane compounds, in particular to a method for treating the raw materials of taxane compounds by means of recrystallization, so as to prepare anhydrous crystalline taxanes with good stability and high purity compound method. Background technique [0002] Taxanes are a class of compounds extracted or semi-synthesized from the bark and needles of Taxus celebica, which have high-efficiency and broad-spectrum anti-tumor activity. Taxanes are new anti-tumor drugs that have been researched and developed in recent years. They can bind to tubulin subunits to inhibit microtubule dynamics, and can also induce tumor cell apoptosis by activating multiple signal transduction pathways. Different from other plant alkaloids, taxanes inhibit the cell in G phase and M phase by promoting the assembly of microtubule dimers into microtubules, and stabilizing microtubules by preventing the process of depolymerization...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D305/14C07F7/18C07F7/20C07D413/12
Inventor 张平孙婧张五军张仰明
Owner BIOCOMPOUNDS PHARMACEUTICAL INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products